# US 2023/0057308 A1 · Prediction of biological role of tissue receptors

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0057308 A1
- Document ID: US20230057308A1
- Status: Published application
- Kind: A1
- Application number: 17/980,358
- Filed: 2022-11-03
- Published: 2023-02-23
- Earliest claimed: 2020-05-04
- Assignees: Carmel-Haifa University Economic Corp. Ltd.
- Applicants: Carmel Haifa University Economic Corporation Ltd.
- Inventors: Judith SOMEKH
- Web page: https://patentgrep.com/patent/US20230057308A1

## CPC

- G06N 20/10: using kernel methods, e.g. support vector machines [SVM]
- G06F 18/2155: {characterised by the incorporation of unlabelled data, e.g. multiple instance learning [MIL], semi-supervised techniques using expectation-maximisation [EM] or naïve labelling}
- G06F 18/24147: {Distances to closest patterns, e.g. nearest neighbour classification}
- G16B 5/00: ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 40/20: Supervised data analysis
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06F: ELECTRIC DIGITAL DATA PROCESSING (computer systems based on specific computational models G06N)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

Computerized methods to predict or determine if a receptor is associated with a biological process in a target tissue are provided. Methods of training and using a machine learning model to predict or determine if a receptor is associated with a biological process in a target tissue as well as systems and computer program product to do same are also provided.

## Claims

### Claim 1

A method comprising:
training a machine learning model to predict receptors associated with a biological process in a target tissue, on a training set, the method comprising:
receiving a first list of receptors known to be associated with said biological process and expressed in said target tissue and a second list of receptors known to be expressed in said target tissue and not associated with said biological process;
receiving a dataset comprising expression profiles in said target tissue for genes encoding proteins, wherein said proteins include receptors of said first list and receptors of said second list;
applying, to said dataset, gene co-expression network analysis to group said genes into clusters, based on a co-expression relationship between said genes in said target tissue;
applying to said clusters, a pathways enrichment analysis to assign enrichment scores to said clusters for each pathway of said enrichment analysis, wherein said each pathway is a pathway of a specific biological process;
labeling receptors from said first list and receptors from said second list with labels comprising said enrichment score for said each pathway assigned to a cluster containing said gene encoding said receptor;
generating an annotated training set comprising receptors from said first list and receptors from said second list and corresponding labels; and training said machine learning model on said annotated training set to produce a trained machine learning model.

### Claim 2 (depends on 1)

The method of claim 1, wherein said receptors are cell surface receptors, internal receptors within a cell or a combination thereof, said expression profiles are mRNA expression profiles, or both.

### Claim 3

(canceled)

### Claim 4 (depends on 1)

The method of claim 1, wherein said gene co-expression network analysis comprises employing a Weighted Gene Co-Expression Network Analysis (WGCNA) algorithm, said co-expression relationship is determined from said expression profiles or both.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The method of claim 1, wherein said receptors known to be associated with said biological process have been experimentally confirmed to be associated with said biological process, said dataset comprises expression profiles for all genes expressed in said target tissue, or both.

### Claim 7 (depends on 1)

The method of claim 1, wherein said receptors known to not be associated with said biological process are determined using a Positive unlabeled (PU) support vector machines (SVM) bagging algorithm.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1, wherein said pathways enrichment analysis comprises KEGG pathway analysis.

### Claim 10 (depends on 1)

The method of claim 1, wherein said enrichment score is an enrichment score for an entire cluster and not for an individual gene.

### Claim 11 (depends on 1)

The method of claim 1, wherein said machine learning model is selected from a SVM classifier and a k-nearest neighbor (k-NN) classifier.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The method of claim 1, further comprising:
at an inference stage, receiving, as input, a receptor absent from said annotated training set, and enrichment scores for pathways assigned to a cluster of genes containing a gene encoding said receptor absent from said annotated training set, wherein said cluster of genes containing said gene encoding said receptor absent from said annotated training set is generated by co-expression network analysis of expression profiles of genes in said target tissue; and
applying said trained machine learning model to said input to identify a receptor associated with said biological process in said target tissue.

### Claim 14 (depends on 13)

The method of claim 13, wherein said receptor absent from said annotated training set is a receptor of unknown association with said biological process in said target tissue or is a receptor absent from said first list and said second list.

### Claim 15

(canceled)

### Claim 16 (depends on 13)

The method of claim 13, wherein said enrichment scores for pathways assigned to a cluster of genes containing said gene that encodes said receptor absent from said annotated training set are generated by a method comprising: receiving a dataset comprising expression profiles in said target tissue for genes encoding proteins, wherein said proteins include said receptor absent from said annotated training set, applying, to said dataset, co-expression network analysis to group said genes into clusters, based on a co-expression relationship between said genes in said target tissue; and applying to said clusters, a pathways enrichment analysis to assign enrichment scores to said clusters for each pathway of said enrichment analysis, wherein said each pathway is a pathway of a specific biological process.

### Claim 17

A method comprising:
receiving, as input, a dataset comprising gene expression profiles with respect to a plurality of genes associated with a corresponding plurality of tissues, wherein at least one of said genes encode a receptor;
applying, to said dataset, gene co-expression network analysis to group said genes into tissue-specific clusters, based on a co-expression relationship between said genes in tissues of said plurality of tissues;
applying, to said tissue-specific clusters, a pathways enrichment analysis to assign an enrichment score to said tissue-specific clusters, wherein at least one of said pathways is a pathway of a specific biological process; and
identifying a gene encoding a receptor included in more than one cluster having an enrichment score for a pathway of said specific biological process above a predetermined threshold as a receptor which is associated with said specified biological process.

### Claim 18 (depends on 17)

The method of claim 17, wherein said receptor is selected from a cell surface receptors and an internal receptor within a cell, said expression profiles are mRNA expression profiles or both.

### Claim 19

(canceled)

### Claim 20 (depends on 17, 18, 19)

The method of claim 17 to 19, wherein said gene co-expression network analysis comprises employing a Weighted Gene Co-Expression Network Analysis (WGCNA) algorithm.

### Claim 21 (depends on 17)

The method of claim 17, wherein said identifying comprises at least one of:
a. identifying genes encoding receptors included in at least five clusters having an enrichment score for a pathway of said specific biological process above a predetermined threshold;
b. identifying genes encoding receptors with correlation to an eigengene of said cluster above a predetermined threshold; and
c. applying a machine learning model trained on receptors associated with said biological process and receptors not associated with said biological process.

### Claim 22

(canceled)

### Claim 23

(canceled)

### Claim 24 (depends on 21)

The method of claim 21, wherein said machine learning model is trained by a method comprising:
receiving a first list of receptors known to be associated with said biological process and expressed in said target tissue and a second list of receptors known to be expressed in said target tissue and not associated with said biological process;
receiving a dataset comprising expression profiles in said target tissue for genes encoding proteins, wherein said proteins include receptors of said first list and receptors of said second list;
applying, to said dataset, gene co-expression network analysis to group said genes into clusters, based on a co-expression relationship between said genes in said target tissue;
applying to said clusters, a pathways enrichment analysis to assign enrichment scores to said clusters for each pathway of said enrichment analysis, wherein said each pathway is a pathway of a specific biological process;
labeling receptors from said first list and receptors from said second list with labels comprising said enrichment score for said each pathway assigned to a cluster containing said gene encoding said receptor;
generating an annotated training set comprising receptors from said first list and receptors from said second list and corresponding labels; and
training said machine learning model on said annotated training set to produce a trained machine learning model.

### Claim 25

A method of determining if a receptor is associated with a biological process in a target tissue, the method comprising:
receiving, as input, a receptor of unkonwn association with said biological process in said target tissue, and enrichment scores for pathways assigned to a cluster of genes containing a gene encoding said receptor of unknown association, wherein said cluster is generated by gene co-expression network analysis of expression profiles in said target tissue of a set of genes which includes said gene encoding said receptor of unknown association; and
applying a trained machine learning model to said input to determine if said receptor of unknown association is associated with said biological process in said target tissue, wherein said trained machine learning model has been trained on a training set comprising a first list of receptors known to be associated with said biological process and expressed in said target tissue labeled with labels comprising enrichment scores for pathways assigned to a cluster of genes containing a gene encoding said receptors of said first list, and a second list of receptors known to be expressed in said target tissue and not associated with said biological process labeled with labels comprising enrichment scores for pathways assigned to a cluster of genes containing a gene encoding receptors of said second list;
thereby determining if a receptor is associated with a biological process in a target tissue.

### Claim 26 (depends on 25)

The method of claim 25, wherein at least one of:
a. said receptors are cell surface receptors, internal receptors within a cell or a combination thereof;
b. said expression profiles are mRNA expression profiles;
c. said gene co-expression network analysis comprises employing a Weighted Gene Co-Expression Network Analysis (WGCNA) algorithm
d. said receptors known to be associated with said biological process have been experimentally confirmed to be associated with said biological process;
e. said receptors known to not be associated with said biological process are determined using a Positive unlabeled (PU) support vector machines (SVM) bagging algorithm;
f. said pathways enrichment analysis comprises KEGG pathway analysis;
g. said enrichment score is an enrichment score for an entire cluster and not for an individual gene; and
h. said machine learning model is selected from a SVM classifier and a k-nearest neighbor (k-NN) classifier.

### Claim 27

(canceled)

### Claim 28

(canceled)

### Claim 29

(canceled)

### Claim 30

(canceled)

### Claim 31

(canceled)

### Claim 32

(canceled)

### Claim 33

(canceled)

### Claim 34

(canceled)

### Claim 35 (depends on 1)

A system comprising:
at least one hardware processor; and
a non-transitory computer-readable storage medium having stored thereon program code, the program code executable by the at least one hardware processor to perform a method of claim 1.

### Claim 36 (depends on 1)

A computer program product comprising a non-transitory computer-readable storage medium having program code embodied therewith, the program code executable by at least one hardware processor to perform a method of claim 1.
